Wall Street’s investment banking community is preparing for a significant revival in initial public offerings (IPOs) as private equity organisations look to capitalise on the robust US equities markets to divest their flagship holdings.
Several private equity-backed organisations have submitted regulatory paperwork for IPOs, including healthcare equipment manufacturer Medline and technology firm Genesys. Market experts anticipate a surge of listing announcements in early 2025, bolstered by exceptional US stock market gains in 2024 and optimistic expectations surrounding president-elect Donald Trump’s proposed deregulation and tax reduction policies.
The market’s confidence has been reinforced by strong post-listing performance metrics. Nine out of the ten largest IPOs in 2024 concluded the year trading above their initial listing prices, with half achieving remarkable triple-digit gains, spearheaded by social media platform Reddit.
This anticipated surge follows a three-year drought in US IPOs, triggered by the Federal Reserve’s aggressive interest rate hikes beginning in 2022. The higher rates diminished investor appetite for new listings, particularly affecting high-risk assets and growth-focused companies valued on future earnings potential.
The fintech sector is poised to take centre stage in early 2025, with Swedish buy-now-pay-later service Klarna expected to lead the charge among venture-backed enterprises entering the public markets. San Francisco-based digital banking platform Chime has also revived its public offering plans, with previous valuation discussions ranging between £15 billion and £20 billion.
While the IPO market revival may not match the extraordinary levels seen during the pandemic era, when listings peaked at £150 billion in 2021, market specialists project activity to exceed the pre-2020 average of £38 billion. This renaissance is partly driven by private equity firms facing pressure to generate returns for investors after the extended period of limited deal activity.
The shift also reflects evolved investor preferences following losses on speculative start-up investments during the pandemic-era IPO boom. Contemporary market participants are displaying a marked preference for established, profitable enterprises over early-stage growth companies.
Post Disclaimer
The following content has been published by Stockmark.IT. All information utilised in the creation of this communication has been gathered from publicly available sources that we consider reliable. Nevertheless, we cannot guarantee the accuracy or completeness of this communication.
This communication is intended solely for informational purposes and should not be construed as an offer, recommendation, solicitation, inducement, or invitation by or on behalf of the Company or any affiliates to engage in any investment activities. The opinions and views expressed by the authors are their own and do not necessarily reflect those of the Company, its affiliates, or any other third party.
The services and products mentioned in this communication may not be suitable for all recipients, by continuing to read this website and its content you agree to the terms of this disclaimer.